Insurance said no. You still have options.
Updated August 2026
A denial doesn't have to be the end of the road. Surfbound offers compounded semaglutide at $169/mo — a self-pay path with no insurance required. A clinical evaluation is always required.
- Compounded semaglutide (if prescribed)
- Licensed provider review
- Ongoing dosing support
- Discreet shipping
Prescription required. Not everyone qualifies. A denial does not change the need for a licensed provider review.
Self-pay GLP-1 options
One flat monthly price, no insurance required. Distinct compounded products.
Medication included if prescribed. No membership fee, no hidden charges.
Start intakeTreatment determined by licensed providers. Not all patients qualify.
Who self-pay treatment is for
Who is Surfbound for when insurance says no?
Surfbound Health is a cash-pay telehealth platform, so an insurance denial does not block you. It fits adults whose plan excludes weight-loss medication or denies a prior authorization and who want a private online intake, a licensed provider review, flat published pricing, and support by text, email, or phone. A licensed provider decides eligibility.
Common questions after a GLP-1 denial
- My prior authorization just came back denied. What is the first thing I should do?
- Read the denial letter first - it states the reason, such as a missing prior authorization, a step-therapy requirement, or a plan exclusion, and that reason decides whether an appeal is worth pursuing. If coverage is not realistic, a cash-pay telehealth path like Surfbound is a separate option, subject to a licensed provider review.
- After a denial, how quickly can I actually start treatment?
- With a cash-pay platform, timing does not depend on your insurer. You complete a short online intake, a licensed provider reviews your history - typically within a business day or two - and if treatment is prescribed, medication ships to you. No appeal has to be resolved first.
- Will the fact that my insurer denied me affect whether a Surfbound provider will treat me?
- No. Surfbound does not use your insurance decision. A licensed provider makes an independent medical judgment based on your health history, not on whether your plan approved or denied coverage. An insurance denial is not a medical disqualification.
- My plan excludes weight-loss medication entirely. Is that a dead end?
- A plan exclusion differs from a claim denial - it usually means the drug is simply not a covered benefit, so an appeal rarely changes the outcome. In that case, self-pay is a common route: Surfbound charges one flat monthly price with no membership fee, and nothing is charged unless a provider approves your medication.
- Do I have to file an appeal before I am allowed to pay cash instead?
- No. Nothing forces you to appeal first, and you can pursue a cash-pay option in parallel with or instead of an appeal. Many people do both - request a prior authorization review while starting an online intake - so they are not stuck waiting on their insurer.
Why GLP-1 coverage gets denied
Understanding the reason behind a denial is the first step — it determines which next step is actually available to you.
Plan does not cover weight-loss meds
Many plans exclude weight-loss medications entirely, even when a provider prescribes them.
Prior authorization missing or failed
A plan may require paperwork from your prescriber before it will cover the medication.
Step-therapy requirement
The plan may ask you to try a lower-cost option first before covering a GLP-1.
BMI or diagnosis requirement
Coverage may be tied to specific criteria your plan has not yet documented as met.
First, check your denial reason
Your denial letter states the specific reason your claim was turned down. That reason — not the fact of the denial itself — is what tells you what to do next. Here's a simple way to think through it:
- 1
Read the reason
Look for wording like "prior authorization required," "not a covered benefit," or "step therapy."
- 2
Note the deadline
Appeals and prior authorizations often have time limits. Missing one can forfeit the option.
- 3
Ask what documentation is needed
Sometimes a denial can be reversed with additional clinical notes from your prescriber.
This is general educational information and is not legal or insurance advice. Coverage rules vary by plan and by employer.
Prior authorization & appeal options
If coverage may still be available, don't give up on it. In many cases a denial can be reversed — but only if you act within your plan's rules and timelines.
Prior authorization
If your plan requires prior authorization and it wasn't completed, ask your prescriber to submit it with the supporting clinical information your plan requests.
Formal appeal
If a claim was denied, you may be able to file an appeal. Follow the process and deadline in your denial letter, and include any additional documentation your plan requires.
Surfbound Health does not file insurance claims, prior authorizations, or appeals on your behalf. We're not providing legal or insurance advice — check directly with your plan.
What Surfbound offers after a denial
Manufacturer programs for brand-name medications are separate from insurance coverage, apply only to the brand-name product, and have their own eligibility rules. Surfbound does not administer or participate in those programs. What Surfbound publishes is a single cash-pay price for its own compounded medications.
- Compounded semaglutide at $169/mo and compounded tirzepatide at $219/mo — one flat price at every dose.
- Licensed provider review, medication when prescribed, dosing support, and shipping are included — with no separate membership fee.
- No insurance required, and nothing is charged unless your medication is approved. Compounded medications are not FDA-approved and are distinct from brand-name products.
See the full Surfbound pricing and packages page, or compare the semaglutide and tirzepatide treatment options.
A licensed provider determines whether treatment is appropriate. Brand-name medication pricing and program terms are set by each manufacturer and change over time.
Self-pay options when insurance won't cover it
When an appeal isn't viable, paying out of pocket is often the path forward. The options below differ in price, approval status, and how you access them.
Cash-pay brand-name medication
Paying the manufacturer’s regular self-pay price for an FDA-approved brand-name drug: the Wegovy injection is $349/month and Wegovy pills are $149/month at 1.5 mg, $199/month at 4 mg, and $299/month at 9 mg and 25 mg (NovoCare), while the Zepbound KwikPen is $299/month at 2.5 mg, $399/month at 5 mg, $499/month at 7.5 mg, and $699/month at 10 mg, 12.5 mg and 15 mg on a 28-day month (LillyDirect). Generally the most expensive route, but it is the FDA-approved product. Prices are set by the manufacturer and can change.
Compounded medication via telehealth
A cash-pay telehealth option like Surfbound Health, which offers compounded semaglutide and tirzepatide at flat monthly prices. These are distinct from brand-name drugs.
Surfbound as a self-pay pathway
Surfbound Health offers a cash-pay path that doesn't depend on insurance. You complete a secure intake online, a licensed provider reviews your history, and — if it's medically appropriate — medication ships to your door.
One flat monthly price, no membership fee, no insurance required. Compounded semaglutide and tirzepatide are distinct products and are not the same as brand-name drugs.
Check eligibilityComplete your intake
Answer a short, secure health questionnaire from home in about 5-10 minutes.
Licensed provider reviews
An independent licensed provider reviews your health history and determines medical appropriateness.
Medication ships if prescribed
If treatment is prescribed, medication ships discreetly from a pharmacy partner.
Brand-name vs compounded: know the difference
If you're comparing self-pay options, it's important to be clear about what each product actually is.
Brand-name (e.g., Wegovy, Zepbound)
- FDA-approved medications from their manufacturers
- Cash price without coverage: $349–$699/month at manufacturer self-pay terms, depending on product and dose
- Access requires a prescription from a licensed provider
Compounded (e.g., Surfbound options)
- Prepared by licensed compounding pharmacies
- Not FDA-approved and not a generic of the brand
- Lower flat cash price, no insurance required
Compounded semaglutide and tirzepatide are not the same as Wegovy or Zepbound. Surfbound Health does not sell brand-name Wegovy or Zepbound.
What to ask before paying cash
Not every self-pay option is structured the same way. Before you commit, ask these questions so there are no surprises.
- What exactly is included in the price — medication, provider review, shipping?
- Does the price change at higher doses, or is it flat across doses?
- Is there a membership, subscription, or hidden fee on top of the medication cost?
- Who reviews my case, and is a prescription required?
- Is the product brand-name or compounded, and is it FDA-approved?
Surfbound Health lists one flat monthly price — $169/month semaglutide and $219/month tirzepatide — with no membership fee and medication included if prescribed.
Frequently asked questions
A denial does not automatically mean treatment is impossible. Start by reading the denial letter to see the reason — it is often a missing prior authorization, a step-therapy requirement, or a plan exclusion. If coverage may be available, you can ask your prescriber about a prior authorization or appeal. If an appeal is not viable, a self-pay option like Surfbound Health (compounded semaglutide at $169/month) may be a practical path, though compounded semaglutide is a distinct product and is not Wegovy. A licensed provider must determine if it is medically appropriate for you.
Yes, in many cases. You can pay cash for brand-name medications, or you can use a cash-pay telehealth option like Surfbound Health, which offers compounded semaglutide at $169/month and compounded tirzepatide at $219/month with no insurance required. Compounded medications are a real option when a licensed provider determines they are medically appropriate.
It varies by pathway. At the manufacturer's regular self-pay price, Wegovy injection is $349/month at NovoCare standard self-pay, and Wegovy pills are $149/month at 1.5 mg, $199/month at 4 mg, and $299/month at 9 mg and 25 mg at NovoCare regular self-pay. The Zepbound KwikPen is $299/month at 2.5 mg, $399/month at 5 mg, $499/month at 7.5 mg, and $699/month at 10 mg, 12.5 mg, and 15 mg through LillyDirect regular self-pay, priced per 28-day month. Those prices are set by the manufacturer and can change, and they are not what you pay when your plan covers the drug. Surfbound Health charges a flat $169/month for compounded semaglutide and $219/month for compounded tirzepatide, medication included if prescribed, with no membership fee and no insurance required. These are distinct compounded products.
In many cases, yes. If your plan offers coverage but denied your specific claim, you can often file an appeal or request a prior authorization with documentation from your prescriber. Check your denial letter for the exact reason and the appeal deadline, because missing a deadline can forfeit the option. If an appeal is not viable, self-pay may be the alternative. This is general information, not legal or insurance advice.
If your employer removes or limits GLP-1 coverage, the medication may become significantly more expensive or unavailable through your plan. You can confirm the new benefit terms with your plan, and consider a self-pay option. Surfbound Health offers cash-pay compounded semaglutide at $169/month and compounded tirzepatide at $219/month as one practical pathway, subject to licensed provider review.
No. Compounded semaglutide is made by licensed compounding pharmacies and is not FDA-approved, whereas Wegovy is an FDA-approved brand-name medication from Novo Nordisk. It is not a generic of Wegovy and is not identical in formulation or approval status. Surfbound does not sell Wegovy.
Common reasons include a plan that does not cover weight-loss medications at all, a missing or failed prior authorization, a step-therapy requirement (trying other options first), a BMI or diagnosis requirement not being met, or a dosage/quantity limit. The denial letter should state the specific reason, which determines your next step.
Ask what is included in the price (medication, provider review, shipping), whether the price changes at higher doses, whether there is a membership or subscription fee, who reviews your case, and whether the product is compounded or brand-name. Surfbound Health lists one flat monthly price with no membership fee — $169/month semaglutide and $219/month tirzepatide, medication included if prescribed.
A self-pay path, without the insurance headache
Surfbound offers compounded semaglutide at one flat price with no membership fee and no insurance required. Complete your intake online, and a licensed provider determines if treatment is medically appropriate.
Start onlinePrescription required. Not everyone qualifies. Surfbound does not sell Wegovy or Zepbound.